4//SEC Filing
Kumar Ravindra 4
Accession 0001179110-17-011284
CIK 0001280600other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:32 PM ET
Size
8.7 KB
Accession
0001179110-17-011284
Insider Transaction Report
Form 4
Kumar Ravindra
VP & Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2017-08-08$24.11/sh+13,065$314,997→ 108,392 total - Sale
Common Stock
2017-08-08$35.41/sh−13,065$462,632→ 95,327 total - Exercise/Conversion
Option to Purchase Common Stock
2017-08-08−13,065→ 3,624 totalExercise: $24.11Exp: 2023-12-05→ Common Stock (13,065 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $35.84 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.
Documents
Issuer
ACCELERON PHARMA INC
CIK 0001280600
Entity typeother
Related Parties
1- filerCIK 0001586835
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:32 PM ET
- Size
- 8.7 KB